Science & Education · 2026
Tissue Engineering Explained: How Cells, Scaffolds and Biological Signals Work Together
Learn how tissue engineering combines cells, scaffolds, extracellular matrix, biological signals and engineering principles to repair or replace damaged tissues.
In 1993, Robert Langer and Joseph Vacanti published a landmark article in Science describing an emerging field called tissue engineering.
The central idea was ambitious: principles from biology and engineering could be combined to create functional substitutes for damaged tissue.
More than three decades later, that concept has grown into one of the major foundations of regenerative medicine.
Modern tissue engineering now includes biomaterials, stem-cell science, extracellular-matrix biology, three-dimensional fabrication, biomechanics, controlled biological signaling and advanced manufacturing.
Yet the fundamental problem remains the same.
How can we recreate enough of a tissue's biological environment to restore useful function?
What Is Tissue Engineering?#
Tissue engineering is an interdisciplinary field that applies principles from engineering and life sciences to the development of biological substitutes capable of restoring, maintaining or improving tissue function.
The word engineering is important.
Natural tissues are not simply collections of cells.
They possess architecture.
They have mechanical properties.
They receive nutrients through organized vascular systems.
Their cells communicate using chemical and physical signals.
Their extracellular matrices are arranged differently depending on the function of each tissue.
Tissue engineers therefore attempt to control multiple variables rather than simply placing cells into a damaged area and expecting a new tissue to form.
The Classic Tissue-Engineering Model#
- A useful framework involves three major components:
- cells, which perform biological functions
- scaffolds, which provide a three-dimensional environment
and signals, which influence cell behaviour.
This model is simplified, but it remains useful.
For example, a tissue-engineered construct may contain cells seeded onto a porous biomaterial. The scaffold provides physical support, while growth factors or matrix-derived signals influence proliferation, migration or differentiation.
More sophisticated designs may add controlled degradation, mechanical stimulation or vascular features.
The objective is to reproduce enough of the native microenvironment to produce a useful biological response.
Why Cells Alone Are Often Not Enough#
Cells respond strongly to their surroundings.
A cell removed from its natural tissue and placed on a flat laboratory surface experiences a radically different environment.
In the body, that same cell interacts with neighbouring cells, extracellular proteins, soluble signals and mechanical forces.
The stiffness of the surrounding material can matter.
The orientation of fibres can matter.
Pore size and geometry can matter.
The presence of specific matrix-binding molecules can matter.
This is why modern tissue engineering increasingly focuses on the cell–matrix interface.
The scaffold is not merely packaging for the cells.
It can be part of the biological information presented to them.
What Is a Tissue Scaffold?#
A scaffold is a three-dimensional structure designed to support tissue formation or tissue interaction.
Scaffolds can be manufactured from synthetic polymers, natural polymers or processed biological tissues.
Synthetic materials offer several advantages.
Their chemistry can often be controlled precisely. Their strength, degradation and geometry can be engineered. Manufacturing can be reproducible.
Natural materials may provide biological characteristics that are more difficult to recreate synthetically.
Collagen, gelatin, hyaluronic-acid-derived materials and fibrin are examples of natural biomaterial systems investigated in tissue engineering.
Another category consists of decellularized extracellular-matrix scaffolds.
Instead of manufacturing an entirely new architecture, these materials begin with an existing tissue and remove its cells while attempting to preserve the extracellular framework.
Why Extracellular Matrix Changed Tissue Engineering#
Early tissue engineering often emphasized scaffold shape and mechanical support.
Modern extracellular-matrix research expanded that model.
The ECM is now understood as a dynamic environment that influences cell behaviour.
Its structural proteins provide mechanical support, but its importance is not limited to mechanics.
Matrix molecules can interact with cell-surface receptors. Bound molecules can influence local signalling. The matrix can also act as a reservoir for biochemical factors.
Mechanical forces transmitted between a cell and the surrounding matrix can alter intracellular signalling—a process broadly described as mechanotransduction.
Therefore, two scaffolds with similar external shape may behave very differently biologically.
Their internal architecture, composition and mechanical characteristics can matter just as much as their gross geometry.
Biological Versus Synthetic Scaffolds#
There is no universal answer to the question of whether biological or synthetic scaffolds are better.
The correct material depends on the intended use.
A synthetic scaffold may be preferable where precise mechanical performance and manufacturing consistency are critical.
A biological matrix may be attractive where tissue-derived architecture or biochemical complexity is desirable.
Composite materials can attempt to combine these advantages.
For example, researchers may strengthen a biologically derived material with a synthetic polymer, or add extracellular-matrix components to a synthetic hydrogel.
This reflects a broader change in tissue engineering.
The field is moving away from simple categories and toward materials designed around specific biological requirements.
Tissue-Specific Engineering#
Skin, tendon, cartilage, nerve and heart tissue perform very different functions.
It would therefore be surprising if a single scaffold design were optimal for all of them.
Skin requires a flexible and highly organized dermal environment.
Tendon is adapted to transmit tensile forces.
Cartilage experiences compression and has limited vascularity.
Cardiac tissue must repeatedly contract.
Nerve tissue requires directional organization capable of supporting communication over long distances.
This is why tissue-specific extracellular matrices have attracted interest.
A decellularized matrix retains at least some features associated with the original tissue, although the extent of preservation depends heavily on processing.
The goal is not to claim that a decellularized scaffold perfectly recreates native tissue.
It does not.
Rather, the concept is that native tissue may provide an architectural and biochemical starting point that is difficult to reproduce from scratch.
Vascularization: One of the Central Challenges#
Cells require oxygen and nutrients.
Thin tissue constructs can receive these materials through diffusion over short distances.
Large or metabolically active tissues cannot.
This creates one of the major challenges in regenerative medicine: vascularization, or the establishment of a functional blood-vessel network.
Without adequate vascular support, cells deep within an engineered construct may not survive.
Researchers are investigating many strategies, including porous scaffold architecture, vascular growth signals, pre-formed channels, endothelial cells and advanced bioprinting.
The vascularization problem helps explain why building a large functional organ is substantially more complicated than engineering a thin tissue layer.
Mechanical Properties Matter#
Tissues constantly experience force.
Skin stretches.
Tendons carry tension.
Cartilage is compressed.
Bone carries complex loads.
A scaffold with inappropriate mechanical properties can change cell behaviour or fail structurally.
Tissue engineers therefore evaluate parameters such as stiffness, tensile strength, elasticity and viscoelastic behaviour depending on the application.
Mechanical matching does not necessarily mean making a scaffold identical to native tissue.
The material may need to be temporarily stronger, gradually degradable or designed to transfer load as new tissue develops.
The correct properties depend on the biological and clinical objective.
Where Does Acellular Dermal Matrix Fit?#
Acellular Dermal Matrix is one example of a biological scaffold used within the broader tissue-engineering landscape.
The starting material is dermal tissue.
Processing removes cellular components while attempting to preserve an organized extracellular framework.
The resulting matrix can provide physical structure without requiring clinicians to construct a dermal scaffold from individual purified components.
However, ADM should not be considered equivalent to living dermis.
It does not initially contain the original living cellular population.
Its performance depends on subsequent host interaction and remodeling.
Furthermore, different ADM products may differ significantly because tissue source and processing affect final material characteristics.
Tissue Engineering Versus Regenerative Medicine#
The terms are closely related but not identical.
Tissue engineering typically emphasizes the use of engineering principles to construct or support biological tissues.
Regenerative medicine is broader.
It includes tissue engineering but may also include cell therapy, gene therapy, stimulation of endogenous repair and other strategies that do not require a manufactured scaffold.
In practice, the two fields overlap extensively.
Modern extracellular-matrix research sits directly at that intersection.
It combines tissue biology, materials engineering and regenerative mechanisms.
From Laboratory Concept to Clinical Product#
One of the most difficult stages in tissue engineering is translation from laboratory research to a reproducible clinical product.
A promising scaffold must be manufacturable.
Its characteristics must be measurable.
Batch variation must be controlled.
Storage and packaging must be appropriate.
Biocompatibility and safety require evaluation.
Clinical outcomes must eventually be assessed for the intended use.
These requirements become particularly important for biological materials because the starting tissues themselves may vary.
Scientific innovation therefore represents only one part of tissue engineering.
Quality systems, manufacturing science and regulatory strategy are equally important to successful translation.
Frequently Asked Questions#
Is tissue engineering the same as growing organs in a laboratory?#
No. Whole-organ engineering is one ambitious area of research, but tissue engineering also includes much simpler applications such as scaffolds for localized tissue repair.
Do all tissue-engineered products contain stem cells?#
No. Some contain cells, but many regenerative scaffolds are acellular and rely on interaction with host tissue.
Why are scaffolds porous?#
Porosity can permit fluid movement, tissue ingrowth and cellular infiltration. The optimal pore architecture depends on the material and intended tissue.
Conclusion#
The enduring insight of tissue engineering is that biological repair depends on more than cells.
Cells operate inside structured environments.
Those environments provide mechanical support, spatial organization and biological signals.
Modern tissue engineering therefore studies the interaction between cells, scaffolds, signals and mechanics rather than treating each component in isolation.
This framework provides the scientific foundation for many contemporary regenerative biomaterials—including extracellular-matrix-derived scaffolds and Acellular Dermal Matrix.
References
Scientific references
- Langer R, Vacanti JP. Tissue Engineering. Science. 1993;260(5110):920–926. doi: 10.1126/science.8493529. Official DOIDOI: 10.1126/science.8493529
- Sampogna G, Guraya SY, Forgione A. Regenerative medicine: Historical roots and potential strategies in modern medicine. 2015. doi: 10.1016/j.jmau.2015.05.002. Official DOIDOI: 10.1016/j.jmau.2015.05.002
- Badylak SF, Freytes DO, Gilbert TW. Extracellular matrix as a biological scaffold material: Structure and function. Acta Biomaterialia. 2009;5(1):1–13. Official DOI

Scientific discussion
Comments & questions
Comments are moderated before publication. Official replies are clearly marked as Allograft.ca.